Upload
phungminh
View
230
Download
0
Embed Size (px)
Citation preview
PENGGUNAAN COXIB DALAMTATA LAKSANA NYERI
NOSISEPTIFby Thomas Eko P
Submission date: 05-Dec-2018 09:33AM (UTC+0700)Submission ID: 1050835142File name: Medicina_Coxib_Final.pdf (154.35K)Word count: 4515Character count: 28073
18%SIMILARITY INDEX
17%INTERNET SOURCES
14%PUBLICATIONS
12%STUDENT PAPERS
1 1%
2 1%
3 1%
4 1%
5 1%
6 1%
7 1%
PENGGUNAAN COXIB DALAM TATA LAKSANA NYERINOSISEPTIFORIGINALITY REPORT
PRIMARY SOURCES
arthritis.pure.elsevier.comInternet Source
www.moh.gov.sgInternet Source
K. Holte. "Cyclo-oxygenase 2 inhibitors and therisk of anastomotic leakage after fast-trackcolonic surgery", British Journal of Surgery,06/2009Publicat ion
text-id.123dok.comInternet Source
ampainsoc.orgInternet Source
www.medigraphic.comInternet Source
repository.maranatha.eduInternet Source
Submitted to London School of Hygiene and
8 1%
9 1%
10 1%
11 1%
12 1%
13 1%
14 1%
15 <1%
16 <1%
17 <1%
18 <1%
19 <1%
Tropical MedicineStudent Paper
www.hisro.or.thInternet Source
www.oncoline.nlInternet Source
painrussia.ruInternet Source
www.sfar.orgInternet Source
ami.info.umfcluj.roInternet Source
revue.medhyg.chInternet Source
liu.diva-portal.orgInternet Source
mrj.ima-press.netInternet Source
www.fadona.orgInternet Source
www.alrf.asso.frInternet Source
www.paginamedicala.roInternet Source
20 <1%
21 <1%
22 <1%
23 <1%
24 <1%
25 <1%
26 <1%
27 <1%
www.actipatch.comInternet Source
Submitted to University of Louisiana at MonroeStudent Paper
Rioko Kimiko Sakata, Marcelo HenriqueGomes Nunes. "Analgesics use for kidneyfailure", Revista Dor, 2014Publicat ion
www.sbu.seInternet Source
www.drugs.comInternet Source
www.gp220.ruInternet Source
Parida, Sheetal, Aditya Parekh, Goutam Dey,Sukhen C Ghosh, and Mahitosh Mandal."Molecular inhibition of prostaglandin E2 withGW627368X: Therapeutic potential andpreclinical safety assessment in mousesarcoma model", Cancer Biology & Therapy,2015.Publicat ion
U. S. Akarca. "Gastrointestinal Effects ofSelective and Non-Selective Non-SteroidalAnti- Inflammatory Drugs", Current
28 <1%
29 <1%
30 <1%
31 <1%
32 <1%
33 <1%
34 <1%
35 <1%
36 <1%
Pharmaceutical Design, 05/01/2005Publicat ion
"COX-2 inhibitors (coxibs)", Elsevier BV, 2016Publicat ion
www.pharmacyjobs.co.ukInternet Source
www.growlife.comInternet Source
www.koreascience.or.krInternet Source
ichastaliklaridergisi.orgInternet Source
iv.iiarjournals.orgInternet Source
www.ema.europa.euInternet Source
bdigital.ufp.ptInternet Source
Strand, V.. "Are COX-2 inhibitors preferable tonon-selective non-steroidal anti-inflammatorydrugs in patients with risk of cardiovascularevents taking low-dose aspirin?", The Lancet,20071222/20080104Publicat ion
37 <1%
38 <1%
39 <1%
40 <1%
41 <1%
42 <1%
43 <1%
Exclude quotes On
Exclude bibliography On
Exclude matches < 5 words
edoc.siteInternet Source
Weatherall, M.. "Inconsistencies incardiovascular data from COX-2 inhibitor trials--is it a class effect?", JRSM, 2006.Publicat ion
www.kesimpulan.comInternet Source
www.jpp.krakow.plInternet Source
Stacy, Zachary A, Paul P Dobesh, and Toby CTrujillo. "Cardiovascular Risks ofCyclooxygenase Inhibition", PharmacotherapyThe Journal of Human Pharmacology and DrugTherapy, 2006.Publicat ion
Arzneiverordnungs- Report 2014, 2014.Publicat ion
www.ijp-online.comInternet Source